Pain Market Research Reports & Industry Analysis
In considering the IASP definition, it is important to note that not all potentially tissue-damaging stimuli result in pain. Nociception is the activation of the primary afferent nerves with peripheral terminals that respond differently to noxious stimuli. Nociceptors function primarily to sense and transmit pain signals. Nociception may or may not be perceived as pain, depending on a complex interaction within the nociceptive pathways. If nociceptive stimuli are blocked, pain is not perceived. Finally, it is important to distinguish pain, or nociception, from suffering. Suffering is the state of severe distress associated with events that threaten the intactness of the person. Suffering is an emotion. Pain and suffering are not the same phenomenon.
The person who complained of pain in the heart because of the death of a loved one is suffering rather than experiencing pain as it is defined by the IASP. It is clear that three conditions could exist: 1) suffering occurs in the presence of pain,2) suffering occurs when pain is not present, and 3) pain occurs when suffering is not present. For example, the woman awaiting breast biopsy may suffer because of anticipated loss of her breast. After the biopsy, she may have pain without suffering if the biopsy is negative or pain with suffering if the biopsy is positive for malignancy. Interventions aimed at relieving pain and suffering may have some commonalities, but clearly some interventions for suffering will be inadequate for pain just as some interventions for pain are inadequate for suffering.
Pain Industry Research & Market Reports
-
Global Palliative Care Market (by Type, Age Group, Application, End-User, & Region): Insights and Forecast with Potential Impact of COVID-19 (2022-2027)
... serious or life-threatening disease such as cancer in order to improve their quality of life and make them feel more at ease with their treatment. Palliative care is given to patients suffering from diseases such ... Read More
-
Cannabis Concentrate Market - Global Cannabis Concentrate Industry Analysis, Size, Share, Growth, Trends, Regional Outlook, and Forecast 2023-2030 - (By Type Coverage, By End-use Sector Coverage, By Geographic Coverage and Leading Companies)
... Set to Skyrocket, Reaching US$2.45 Billion by 2030 The global cannabis concentrate market is on an impressive growth trajectory, with market revenue expected to surge from US$1.6 billion in 2022 to a projected US$2.45 billion ... Read More
-
Middle East & Africa Clinical Trials Market Forecast to 2028 - Regional Analysis - by Study Design (Interventional, Observational, and Expanded Access), Phase (Phase I, Phase II, Phase III, and Phase IV), and Indication (Autoimmune/Inflammation, Pain Management, Oncology, CNS Condition, Diabetes, Obesity, Cardiovascular, and Others)
... Pain Management, Oncology, CNS Condition, Diabetes, Obesity, Cardiovascular, and Others) The Middle East & Africa clinical trials market is expected to grow from US$ 1,524.94 million in 2022 to US$ 1,923.39 million by 2028. It ... Read More
-
South & Central America Clinical Trials Market Forecast to 2028 - Regional Analysis - by Study Design (Interventional, Observational, and Expanded Access), Phase (Phase I, Phase II, Phase III, and Phase IV), and Indication (Autoimmune/Inflammation, Pain Management, Oncology, CNS Condition, Diabetes, Obesity, Cardiovascular, and Others)
... Pain Management, Oncology, CNS Condition, Diabetes, Obesity, Cardiovascular, and Others) The South & Central America clinical trials market is expected to grow from US$ 1,794.69 million in 2022 to US$ 2,523.98 million by 2028. It ... Read More
-
Europe Clinical Trials Market Forecast to 2028 - Regional Analysis - by Study Design (Interventional, Observational, and Expanded Access), Phase (Phase I, Phase II, Phase III, and Phase IV), and Indication (Autoimmune/Inflammation, Pain Management, Oncology, CNS Condition, Diabetes, Obesity, Cardiovascular, and Others)
... CNS Condition, Diabetes, Obesity, Cardiovascular, and Others) The Europe clinical trials market is expected to grow from US$ 15,739.35 million in 2022 to US$ 21,643.87 million by 2028. It is estimated to grow at a ... Read More
-
North America Clinical Trials Market Forecast to 2028 - Regional Analysis - by Study Design (Interventional, Observational, and Expanded Access), Phase (Phase I, Phase II, Phase III, and Phase IV), and Indication (Autoimmune/Inflammation, Pain Management, Oncology, CNS Condition, Diabetes, Obesity, Cardiovascular, and Others)
... Oncology, CNS Condition, Diabetes, Obesity, Cardiovascular, and Others) The North America clinical trials market is expected to grow from US$ 27,322.28 million in 2022 to US$ 36,818.15 million by 2028. It is estimated to grow ... Read More
-
Transdermal Drug Delivery System Market Size and Forecasts (2020 - 2030), Global and Regional Share, Trends, and Growth Opportunity Analysis Report Coverage: By Type (Transdermal Patches, Transdermal Gel, Transdermal Sprays, and Others), Application (Cardiovascular Diseases, Central Nervous System Disorders, Pain Management, Hormonal Applications, and Other Applications), and Distribution Channel (Hospitals Pharmacies, Retail Pharmacies, Online Pharmacies, and Others)
... Central Nervous System Disorders, Pain Management, Hormonal Applications, and Other Applications), and Distribution Channel (Hospitals Pharmacies, Retail Pharmacies, Online Pharmacies, and Others) The global transdermal drug delivery systems market is expected to reach US$ 51.949 ... Read More
-
Asia Pacific Clinical Trials Market Forecast to 2028 – Regional Analysis – by Study Design (Interventional, Observational, and Expanded Access), Phase (Phase I, Phase II, Phase III, and Phase IV), and Indication (Autoimmune/Inflammation, Pain Management, Oncology, CNS Condition, Diabetes, Obesity, Cardiovascular, and Others)
... Oncology, CNS Condition, Diabetes, Obesity, Cardiovascular, and Others) The Asia Pacific clinical trials market is expected to grow from US$ 8,670.68 million in 2022 to US$ 13,114.04 million by 2028. It is estimated to grow ... Read More
-
Global Paracetamol,Caffeine,Artificial Cow-Bezoar,Chlorphenamine Maleate Capsules Market Growth 2023-2029
... downstream market, the Paracetamol,Caffeine,Artificial Cow-Bezoar,Chlorphenamine Maleate Capsules is forecast to a readjusted size of US$ million by 2029 with a CAGR of % during review period. The research report highlights the growth potential of the ... Read More
-
Global Patient-controlled Analgesic Pumps Market Professional Survey by Types, Applications, and Players, with Regional Growth Rate Analysis and Development Situation, from 2023 to 2028
... growth of the Patient-controlled Analgesic Pumps industry between the year 2018 to 2028, and breaks down according to the product type, downstream application, and consumption area of Patient-controlled Analgesic Pumps. The report also introduces players ... Read More
-
OTC Analgesics Market Outlook to 2030- Forecasts of Market Size, Share, Companies, Countries, Trends, Opportunities, and Industry Developments Report
... an optimistic growth between 2024 and 2030. Robust demand from end-user industries, widening applications, and investments in new technologies support the long-term market growth potential. The late-2023 edition- “OTC Analgesics Market Outlook to 2030- Forecasts ... Read More
-
Neurostimulation Device Market Outlook to 2030- Forecasts of Market Size, Share, Companies, Countries, Trends, Opportunities, and Industry Developments Report
... an optimistic growth between 2024 and 2030. Robust demand from end-user industries, widening applications, and investments in new technologies support the long-term market growth potential. The late-2023 edition- “Neurostimulation Device Market Outlook to 2030- Forecasts ... Read More
-
Neuropathic Pain Market Outlook to 2030- Forecasts of Market Size, Share, Companies, Countries, Trends, Opportunities, and Industry Developments Report
... an optimistic growth between 2024 and 2030. Robust demand from end-user industries, widening applications, and investments in new technologies support the long-term market growth potential. The late-2023 edition- “Neuropathic Pain Market Outlook to 2030- Forecasts ... Read More
-
Global Cannabidiol Oil Market 2023-2030
... Forecast Period (2023-2030) The global cannabidiol oil market is anticipated to grow at a considerable CAGR of 16.3% during the forecast period. The increased awareness about the benefits of cannabidiol and its medicinal properties has ... Read More
-
Saudi Arabia Pain Management Market Research Report Forecast to 2030
... products and techniques, which are driving the growth of the Saudi Arabia pain management market. However, the side effects associated with treatments are attributed to retarding market growth. Nonetheless, it is anticipated that increasing investment ... Read More
-
Implications and Growth Opportunities of Metaverse in Healthcare
... applications in healthcare include therapeutics, diagnostics, surgery, and medical education. It enables patients to receive diagnoses, therapy, and remote consultations from the comfort of their homes. Healthcare professionals can leverage the metaverse for a better ... Read More
-
Global Vulvodynia Pain Management Market - 2023-2030
... the forecast period 2023-2030. Vulvodynia is a chronic pain condition of the vulva (outer female genitals). It usually lasts over three months, and there's no known cause. Vulvodynia affects women of all age groups; the ... Read More
-
Global Diabetic Neuropathic Pain Market - 2023-2030
... the forecast period 2023-2030. The development of novel treatments for diabetic neuropathy is a trend for the global diabetic neuropathic pain market. For instance, on July 27, 2023, Gujarat‐based pharma company Asprius Lifesciences announced that ... Read More
-
Global CGRP Inhibitor Market (2023 Edition): Analysis By Treatment (Preventive, Acute), Route of Administration (Oral, Nasal, Intravenous), By End-User, By Region, By Country: Market Insights and Forecast (2019-2029)
... research report titled “Global CGRP Inhibitor Market (2023 Edition)” which provides a complete analysis of the Global CGRP Inhibitor industry in terms of market segmentation by Treatment (Preventive, Acute), By Route of Administration (Oral, Nasal, ... Read More
-
Home Infusion Therapy Market, Size, Global Forecast 2023-2030, Industry Trends, Growth, Share, Outlook, Impact of Inflation, Opportunity Company Analysis
... according to Renub Research. Home infusion therapy, the administration of drugs in a patient's home, has received reputation for its effectiveness in assuaging numerous conditions, specifically while oral medicinal drugs are much less effective. It ... Read More
-
Arthralgia (Joint Pain) Clinical Trial Analysis by Phase, Trial Status, End Point, Sponsor Type and Region, 2023 Update
... Counts, End Points, Status, Sponsor Type, and Top Countries, 2023 Update provides an overview of Arthralgia (Joint Pain) Clinical trials scenario. This report provides top line data relating to the clinical trials on Arthralgia (Joint ... Read More
-
Global Peripheral Nerve Stimulator Market Forecast to 2030
... rising interest in peripheral nerve stimulators, the ascent in instances of nerve wounds, and the developing interest in remote peripheral nerve stimulators are driving the market development. The utilization of oral meds like Pamelor, Sine ... Read More
-
Asia Pacific Medical Marijuana Market Forecast to 2028 – COVID-19 Impact and Regional Analysis – by Product Type (Dried Form and Extract Form), Application (Pain Management, Tourette’s, Alzheimer’s Disease, Migraines, Depression and Anxiety, Multiple Sclerosis, Cancer, and Others), and Distribution Channel (Retail Pharmacy, E-Commerce, and Others)
... Cancer, and Others), and Distribution Channel (Retail Pharmacy, E-Commerce, and Others) The Asia Pacific medical marijuana market is expected to grow from US$ 2,115.23 million in 2022 to US$ 6,203.80 million by 2028. It is ... Read More
-
North America Medical Marijuana Market Forecast to 2028 – COVID-19 Impact and Regional Analysis – by Product Type (Dried Form and Extract Form), Application (Pain Management, Tourette’s, Alzheimer’s Disease, Migraines, Depression and Anxiety, Multiple Sclerosis, Cancer, and Others), and Distribution Channel (Retail Pharmacy, E-Commerce, and Others)
... Cancer, and Others), and Distribution Channel (Retail Pharmacy, E-Commerce, and Others) The North America medical marijuana market is expected to grow from US$ 7,170.17 million in 2022 to US$ 20,760.41 million by 2028. It is ... Read More
-
Europe Medical Marijuana Market Forecast to 2028 – Regional Analysis – by Product Type (Dried Form and Extract Form), Application (Pain Management, Tourette’s, Alzheimer’s Disease, Migraines, Depression and Anxiety, Multiple Sclerosis, Cancer, and Others), and Distribution Channel (Retail Pharmacy, E-Commerce, and Others)
... Distribution Channel (Retail Pharmacy, E-Commerce, and Others) The Europe medical marijuana market is expected to grow from US$ 3,414.26 million in 2022 to US$ 9,703.38 million by 2028. It is estimated to register a CAGR ... Read More
Research Assistance
